David R. Gastfriend, MD

home / authors / david-r-gastfriend-md

Articles

June 17th 2011

Cost and Utilization Outcomes of Opioid-Dependence Treatments

Onur Baser, MS, PhD Mady Chalk, PhD David A. Fiellin, MD David R. Gastfriend, MD

June 17th 2011

Alcohol Dependence Treatments: Comprehensive Healthcare Costs, Utilization Outcomes, and Pharmacotherapy Persistence

Onur Baser, MS, PhD Mady Chalk, PhD Richard Rawson, PhD David R. Gastfriend, MD

December 16th 2010

Comparison of Healthcare Utilization Among Patients Treated With Alcoholism Medications

Tami L. Mark, PhD Leslie B. Montejano, MA Henry R. Kranzler, MD Mady Chalk, PhD David R. Gastfriend, MD

Treatment of alcohol dependence with medications offered advantages in reduced healthcare utilization and costs compared with usual treatment without medications.

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

Published: July 24th 2024 | Updated: July 27th 2024

Insights from the TROPION-Lung05 Trial at ASCO 2024

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School

Published: July 24th 2024 | Updated: July 27th 2024

Examining Trends, Future Directions in AI and Health Care

Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Alfred L. Garfall, MD, an expert on multiple myeloma

Published: July 24th 2024 | Updated: July 27th 2024

Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions